Region:Global
Product Code:GDME0749EPD
Ventilators-Medical Devices Pipeline Assessment, 2019
Summary
GlobalData's Medical Devices sector report, Ventilators-Medical Devices Pipeline Assessment, 2019" provides an overview of Ventilators currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Ventilators pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Ventilators under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Ventilators and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry.
Reasons to buy
The report enables you to-
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Ventilators under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date.
Certus Critical Care Inc
CoLabs Inc
GE Healthcare LLC
Hamilton Medical AG
Koninklijke Philips NV
Massachusetts Institute of Technology
MC3 Inc
Mergenet Medical, Inc.
Neonatal Rescue LLC
OneBreath Inc.
Philips Healthcare
Philips Respironics Inc
University of California Los Angeles
Ventec Life Systems Inc
Zoll Medical Corp
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Ventilators Overview
3 Products under Development
3.1 Ventilators-Pipeline Products by Stage of Development
3.2 Ventilators-Pipeline Products by Segment
3.3 Ventilators-Pipeline Products by Territory
3.4 Ventilators-Pipeline Products by Regulatory Path
3.5 Ventilators-Pipeline Products by Estimated Approval Date
4 Ventilators-Pipeline Products under Development by Companies
4.1 Ventilators Companies-Pipeline Products by Stage of Development
4.2 Ventilators-Pipeline Products by Stage of Development
5 Ventilators Companies and Product Overview
5.1 Certus Critical Care Inc Company Overview
5.2 CoLabs Inc Company Overview
5.3 GE Healthcare LLC Company Overview
5.4 Hamilton Medical AG Company Overview
5.5 Koninklijke Philips NV Company Overview
5.6 Massachusetts Institute of Technology Company Overview
5.7 MC3 Inc Company Overview
5.8 Mergenet Medical, Inc. Company Overview
5.9 Neonatal Rescue LLC Company Overview
5.10 OneBreath Inc. Company Overview
5.11 Philips Healthcare Company Overview
5.12 Philips Respironics Inc Company Overview
5.13 University of California Los Angeles Company Overview
5.14 Ventec Life Systems Inc Company Overview
5.15 Zoll Medical Corp Company Overview
6 Ventilators- Recent Developments
6.1 Jul 17, 2018: Getinge publishes Interim Report for January-June 2018
6.2 Jul 04, 2018: Getinge enters into an agreement with authority in Brazil
6.3 Jul 04, 2018: GE, Lagos State Government sign agreement on power, healthcare, skills development
6.4 Jun 29, 2018: Todd Ernst Named GE's Vice President of Investor Relations
6.5 Jun 26, 2018: InfuSystem Holdings Selected as an Official Distributor of CADD Infusion Therapy Products by Smiths Medical
6.6 Jun 21, 2018: Fisher & Paykel Healthcare announces new Future Director appointment
6.7 Jun 19, 2018: Cardinal Health Foundation Awards Over USD 3 Million to More Than 70 Nonprofit Organizations to Fight the Opioid Epidemic across Appalachia
6.8 Jun 05, 2018: Medtronic Presents Strategic Growth Roadmap at 2018 Investor Day; Outlines Plan to Create Shareholder Value
6.9 May 28, 2018: Fisher & Paykel Healthcare Announces Record Full Year Result
6.10 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results
6.11 May 22, 2018: BioLineRx Reports First Quarter 2018 Financial Results
6.12 May 20, 2018: New data shows combined COPD treatments could help reduce annual cost of care
6.13 May 16, 2018: ZOLL recognizes nurses as the heart of health care at NTI 2018-ZOLL technologies to be showcased
6.14 May 11, 2018: Teleflex: Reaffirms 2018 Guidance and Provides 3-Year Financial Goals and Objectives
6.15 May 09, 2018: Teijin: Consolidated Financial Statements Summary For the year ended March 31, 2018
6.16 May 07, 2018: Ambu: Interim report for Q2 2017/18 and for the half-year (1 October 2017- 31 March 2018)
6.17 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy
6.18 May 03, 2018: Cardinal Health Announces Third-quarter Results for Fiscal Year 2018
6.19 May 03, 2018: Teleflex Reports First Quarter 2018 Results
6.20 Apr 26, 2018: ResMed Announces Results for the Third Quarter of Fiscal Year 2018
6.21 Apr 26, 2018: Getinge publishes Interim Report for January-March 2018
6.22 Apr 26, 2018: Osi Systems posts Q3 fiscal 2018 results
6.23 Apr 23, 2018: Sanmina Reports Second Quarter Fiscal 2018 Results
6.24 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics
6.25 Apr 02, 2018: ResMed Hires Bobby Ghoshal as First Chief Technology Officer
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.